ORMP
Oramed Pharmaceuticals Inc
4.80$
+1.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 76.1% | 73.7% | 87.0% | 83.2% | 86.5% | 92.2% | 89.1% | 61.2% | 61.7% | 57.7% | 25.3% | 14.4% | |
| 2.4% | 4.1% | 9.1% | 46.0% | 25.5% | 35.0% | 50.5% | 9.8% | 23.7% | 19.9% | 4.9% | 4.1% | |
| 75.8% | 73.5% | 86.7% | 82.9% | 86.2% | 91.4% | 88.5% | 60.6% | 61.1% | 54.5% | 24.5% | 13.7% | |
| – | – | – | – | – | – | – | – | – | 2.0% | – | 0.2% | |
| 35.8% | 26.1% | 18.6% | 4.4% | 5.8% | 6.4% | 5.2% | 5.0% | 8.2% | 13.5% | 11.4% | 14.1% | |
| 33.9% | 24.1% | 16.5% | 2.0% | 3.2% | 3.7% | 3.7% | 2.3% | 2.8% | 8.3% | 3.9% | 2.9% | |
| 32.7% | 23.3% | 15.9% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | |
| 1.1% | 0.2% | 0.6% | 1.9% | 3.0% | 0.5% | 0.3% | 0.4% | 0.3% | 0.2% | 0.2% | 0.1% | |
| 64.6% | 74.3% | 81.8% | 96.1% | 94.8% | 94.2% | 95.4% | 95.6% | 92.2% | 86.5% | 88.6% | 85.9% | |
| -74.0% | -71.4% | -76.6% | -79.7% | -100.8% | -113.7% | -124.9% | -105.7% | -55.6% | -53.5% | -31.7% | -1.9% | |
| 17.5% | 18.3% | 20.4% | 22.6% | 24.8% | 25.7% | 27.9% | 26.4% | 19.4% | 17.5% | 15.6% | 11.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.